The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation (English)
- New search for: Duffy, S. W.
- New search for: Tabar, L.
- New search for: Vitak, B.
- New search for: Yen, M. F.
- New search for: Warwick, J.
- New search for: Smith, R. A.
- New search for: Chen, H. H.
- New search for: Duffy, S. W.
- New search for: Tabar, L.
- New search for: Vitak, B.
- New search for: Yen, M. F.
- New search for: Warwick, J.
- New search for: Smith, R. A.
- New search for: Chen, H. H.
In:
ANNALS OF ONCOLOGY
;
14
;
1196-1198
;
2003
-
ISSN:
- Article (Journal) / Print
-
Title:The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation
-
Contributors:Duffy, S. W. ( author ) / Tabar, L. ( author ) / Vitak, B. ( author ) / Yen, M. F. ( author ) / Warwick, J. ( author ) / Smith, R. A. ( author ) / Chen, H. H. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 14 ; 1196-1198
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2003-01-01
-
Size:3 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 14
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Offlabel use-label off use?Boos, J. et al. | 2003
- 6
-
Pegfilgrastim: the promise of pegylation fulfilledCrawford, J. et al. | 2003
- 9
-
Evidence-based management options for women at increased breast/ovarian cancer riskPichert, G. / Bolliger, B. / Buser, K. / Pagani, O. et al. | 2003
- 20
-
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic eraMiller, K. D. / Sweeney, C. J. / Sledge, G. W. et al. | 2003
- 29
-
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyGreen, M. D. / Koelbl, H. / Baselga, J. / Galid, A. / Guillem, V. / Gascon, P. / Siena, S. / Lalisang, R. I. / Samonigg, H. / Clemens, M. R. et al. | 2003
- 36
-
Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapyAlexandre, J. / Gross-Goupil, M. / Falissard, B. / Nguyen, M.-L. / Gornet, J.-M. / Misset, J.-L. / Goldwasser, F. et al. | 2003
- 42
-
Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in childrenConroy, S. / Newman, C. / Gudka, S. et al. | 2003
- 48
-
Psychological responses of patients receiving a diagnosis of cancerSchofield, P. E. / Butow, P. N. / Thompson, J. F. / Tattersall, M. H. N. / Beeney, L. J. / Dunn, S. M. et al. | 2003
- 57
-
Oncology health care professionals' attitudes to cancer: a professional concernKearney, N. / Miller, M. / Paul, J. / Smith, K. / Rice, A. M. et al. | 2003
- 62
-
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancerTominaga, T. / Adachi, I. / Sasaki, Y. / Tabei, T. / Ikeda, T. / Takatsuka, Y. / Toi, M. / Suwa, T. / Ohashi, Y. et al. | 2003
- 71
-
Cancer risk in women with previous breast cancerLevi, F. / Te, V.-C. / Randimbison, L. / La Vecchia, C. et al. | 2003
- 74
-
Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed studyMorice, P. / Brehier-Ollive, D. / Rey, A. / Atallah, D. / Lhomme, C. / Pautier, P. / Pomel, C. / Camatte, S. / Duvillard, P. / Castaigne, D. et al. | 2003
- 78
-
Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in ItalyAugustin, L. S. A. / Polesel, J. / Bosetti, C. / Kendall, C. W. C. / La Vecchia, C. / Parpinel, M. / Conti, E. / Montella, M. / Franceschi, S. / Jenkins, D. J. A. et al. | 2003
- 85
-
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancerGazzaniga, P. / Gradilone, A. / Giuliani, L. / Gandini, O. / Silvestri, I. / Nofroni, I. / Saccani, G. / Frati, L. / Agliano, A. M. et al. | 2003
- 91
-
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumoursO Sullivan, J. M. / Huddart, R. A. / Norman, A. R. / Nicholls, J. / Dearnaley, D. P. / Horwich, A. et al. | 2003
- 97
-
Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trialScheithauer, W. / Schull, B. / Ulrich-Pur, H. / Schmid, K. / Raderer, M. / Haider, K. / Kwasny, W. / Depisch, D. / Schneeweiss, B. / Lang, F. et al. | 2003
- 105
-
An endogastric capsule for measuring tumor markers in gastric juice: an evaluation of the safety and efficacy of a new diagnostic toolMuretto, P. / Graziano, F. / Staccioli, M. P. / Barbanti, I. / Bartolucci, A. / Paolini, G. / Giordano, D. / Testa, E. / De Gaetano, A. et al. | 2003
- 110
-
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a phase I-II studyRoth, A. D. / Allal, A. S. / Brundler, M.-A. / de Peyer, R. / Mermillod, B. / Morel, P. / Huber, O. et al. | 2003
- 116
-
Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III studyMattson, K. V. / Abratt, R. P. / Velde, G. t. / Krofta, K. et al. | 2003
- 123
-
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's diseaseJerusalem, G. / Beguin, Y. / Fassotte, M. F. / Belhocine, T. / Hustinx, R. / Rigo, P. / Fillet, G. et al. | 2003
- 131
-
Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registryKrol, A. D. G. / le Cessie, S. / Snijder, S. / Kluin-Nelemans, J. C. / Kluin, P. M. / Noordijk, E. M. et al. | 2003
- 140
-
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL/TAMO Spanish Cooperative GroupCaballero, M. D. / Perez-Simon, J. A. / Iriondo, A. / Lahuerta, J. J. / Sierra, J. / Marin, J. / Gandarillas, M. / Arranz, R. / Zuazu, J. / Rubio, V. et al. | 2003
- 152
-
Detection of malignant bone marrow involvement with dynamic contrast-enhanced magnetic resonance imagingMoulopoulos, L. A. / Maris, T. G. / Papanikolaou, N. / Panagi, G. / Vlahos, L. / Dimopoulos, M. A. et al. | 2003
- 159
-
Lung cancer mortality in European regions (1955-1997)Borras, J. M. / Fernandez, E. / Gonzalez, J. R. / Negri, E. / Lucchini, F. / La Vecchia, C. / Levi, F. et al. | 2003
- 162
-
Fibre intake and laryngeal cancer riskPelucchi, C. / Talamini, R. / Levi, F. / Bosetti, C. / La Vecchia, C. / Negri, E. / Parpinel, M. / Franceschi, S. et al. | 2003
- 169
-
High-dose methotrexate clearance following prior vancomycin administration: no significant interaction in the absence of overt renal impairmentShamash, J. / Joel, S. / Lundholm, L. / Millard, L. / Oliver, T. et al. | 2003
- 170
-
Comment on "A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer", by C. M. Rudin et al. (Ann Oncol 2002; 13: 539-545)Gautschi, O. / Zangemeister-Wittke, U. / Stahel, R. A. et al. | 2003
- 171
-
Rituximab monotherapy in nodular lymphocyte-predominant Hodgkin's diseaseBoulanger, E. / Meignin, V. / Leverger, G. / Solal-Celigny, P. et al. | 2003
- 171
-
Absolute lymphocyte count as a predictive factor for response to monoclonal anti-CD20 antibody therapyDecaudin, D. / Guetz, G. D. / Mathiot, C. / Dumont, J. / Hubert, P. / Vincent-Salomon, A. / Pouillart, P. et al. | 2003
- 173
-
K. Syrigos (ed). Prostate Cancer: Biology, Diagnosis and ManagementFizazi, K. et al. | 2003
- 173
-
V.A. Levin (ed). Cancer in the Nervous Systemvan den Bent, M. J. et al. | 2003
- 174
-
M. Ponz de Leon (ed). Colorectal CancerKerr, D. J. et al. | 2003
- 174
-
B.W.S. Robinson, A.P. Chahinian (eds). MesotheliomaBard, M. et al. | 2003
- 174
-
C. Ripamonti, E. Bruera (eds). Gastrointestinal Symptoms in Advanced Cancer PatientsKerr, D. J. et al. | 2003
- 174
-
L.B. Saltz (ed). Colorectal Cancer: Multimodality ManagementKerr, D. J. et al. | 2003
- 175
-
Chemotherapy in gastric cancer: a never ending sagaRoth, A. D. et al. | 2003
- 178
-
Prediction of response to therapy by biomolecular markers: from the research laboratory to the clinicMenard, S. / Campiglio, M. / Balsari, A. et al. | 2003
- 181
-
The pharmacological treatment of aggressive fibromatosis: a systematic reviewJaninis, J. / Patriki, M. / Vini, L. / Aravantinos, G. / Whelan, J. S. et al. | 2003
- 191
-
The unknown biology of the unknown primary tumour: a literature reviewvan de Wouw, A. J. / Jansen, R. L. H. / Speel, E. J. M. / Hillen, H. F. P. et al. | 2003
- 197
-
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancerKruijtzer, C. M. F. / Boot, H. / Beijnen, J. H. / Lochs, H. L. / Parnis, F. X. / Planting, A. S. T. / Pelgrims, J. M. G. / Williams, R. / Mathot, R. A. A. / Rosing, H. et al. | 2003
- 205
-
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)Cascinu, S. / Labianca, R. / Catalano, V. / Barni, S. / Ferrau, F. / Beretta, G. D. / Frontini, L. / Foa, P. / Pancera, G. / Priolo, D. et al. | 2003
- 209
-
Cigarette tar yield and risk of upper digestive tract cancers: case-control studies from Italy and SwitzerlandGallus, S. / Altieri, A. / Bosetti, C. / Franceschi, S. / Levi, F. / Negri, E. / Maso, L. D. / Conti, E. / Zambon, P. / La Vecchia, C. et al. | 2003
- 214
-
Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancerSultana, H. / Kigawa, J. / Kanamori, Y. / Itamochi, H. / Oishi, T. / Sato, S. / Kamazawa, S. / Ohwada, M. / Suzuki, M. / Terakawa, N. et al. | 2003
- 220
-
Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinomaBerclaz, G. / Karamitopoulou, E. / Mazzucchelli, L. / Rohrbach, V. / Dreher, E. / Ziemiecki, A. / Andres, A.-C. et al. | 2003
- 227
-
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancerBaldini, E. / Gardin, G. / Giannessi, P. G. / Evangelista, G. / Roncella, M. / Prochilo, T. / Collecchi, P. / Rosso, R. / Lionetto, R. / Bruzzi, P. et al. | 2003
- 233
-
Idoxifene versus tamoxifen: a randomized comparison in postmenopausal patients with metastatic breast cancerArpino, G. / Krishnan, M. N. / Dinesh, C. D. / Bardou, V. J. / Clark, G. M. / Elledge, R. M. et al. | 2003
- 242
-
Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancerBajetta, E. / Stani, S. C. / De Candis, D. / Zaffaroni, N. / Zilembo, N. / Cortinovis, D. / Aglione, S. / Mariani, L. / Formisano, B. / Bidoli, P. et al. | 2003
- 248
-
Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)Tjan-Heijnen, V. C. G. / Caleo, S. / Postmus, P. E. / Ardizzoni, A. / Burghouts, J. T. M. / Buccholz, E. / Biesma, B. / Gorlia, T. / Crott, R. / Giaccone, G. et al. | 2003
- 258
-
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphomaBessell, E. M. / Burton, A. / Haynes, A. P. / Glaholm, J. / Child, J. A. / Cullen, M. H. / Davies, J. M. / Smith, G. M. / Ellis, I. O. / Jack, A. et al. | 2003
- 268
-
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-upCanellos, G. P. / Gollub, J. / Neuberg, D. / Mauch, P. / Shulman, L. N. et al. | 2003
- 273
-
Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphomaCampbell, J. K. / Matthews, J. P. / Seymour, J. F. / Wolf, M. M. / Juneja, S. K. et al. | 2003
- 277
-
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphomaLimat, S. / Demesmay, K. / Voillat, L. / Bernard, Y. / Deconinck, E. / Brion, A. / Sabbah, A. / Woronoff-Lemsi, M. C. / Cahn, J. Y. et al. | 2003
- 282
-
The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's diseaseFlavell, K. J. / Billingham, L. J. / Biddulph, J. P. / Gray, L. / Flavell, J. R. / Constandinou, C. M. / Young, L. S. / Murray, P. G. et al. | 2003
- 291
-
A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesisAapro, M. S. / Thuerlimann, B. / Sessa, C. / de Pree, C. / Bernhard, J. / Maibach, R. et al. | 2003
- 298
-
Phase I study of combined radiation, hyperthermia and intra-arterial carboplatin for local recurrence of cervical cancerTsuda, H. / Tanaka, M. / Manabe, T. / Ikeda, H. / Negoro, S. / Ishiko, O. / Yamamoto, K. et al. | 2003
- 304
-
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsMavroudis, D. / Pappas, P. / Kouroussis, C. / Kakolyris, S. / Agelaki, S. / Kalbakis, K. / Androulakis, N. / Souglakos, J. / Vardakis, N. / Nikolaidou, M. et al. | 2003
- 313
-
Cancer prevalence in Central Europe: the EUROPREVAL StudyLutz, J. M. / Francisci, S. / Mugno, E. / Usel, M. / Pompe-Kirn, V. / Coebergh, J.-W. / Bieslka-Lasota, M. et al. | 2003
- 323
-
Cancer mortality in Ireland, 1926-1995Boyle, P. / Golia, S. / Daly, P. / Johnston, P. G. / Robertson, C. et al. | 2003
- 333
-
Taxane-induced nail changes: incidence, clinical presentation and outcomeMinisini, A. M. / Tosti, A. / Sobrero, A. F. / Mansutti, M. / Piraccini, B. M. / Sacco, C. / Puglisi, F. et al. | 2003
- 339
-
Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acidGedlicka, C. / Kornek, G. V. / Schmid, K. / Scheithauer, W. et al. | 2003
- 340
-
Fatal herpes simplex virus hepatitis complicating chemotherapy with weekly docetaxelHofer, S. / Hunziker, S. / Tornillo, L. / Ludwig, C. U. et al. | 2003
- 341
-
Lethal 5-fluorouracil toxicity associated with a novel mutation in the dihydropyrimidine dehydrogenase genevan Kuilenburg, A. B. P. / Baars, J. W. / Meinsma, R. / van Gennip, A. H. et al. | 2003
- 341
-
Prognostic markers for survival after high-dose chemotherapy with autologous stem-cell transplantation for breast cancerHensel, M. / Ho, A. D. / Bastert, G. / Schneeweiss, A. et al. | 2003
- 342
-
Debate on colorectal cancer screening by faecal occult bloodCastiglione, G. / Zappa, M. et al. | 2003
- 345
-
F.L. Greene, D.L. Page, I.D. Fleming et al. (eds). AJCC Cancer Staging Manuals, 6th editionSchmoll, H.-J. et al. | 2003
- 345
-
M.H. Torosian (ed). Breast Cancer: a Guide to Detection and Multidisciplinary TherapyDel Mastre, L. et al. | 2003
- 346
-
K.I. Bland, J.M. Daly, C.P. Karakousis (eds). Surgical Oncology: Contemporary Principles and PracticeGatzemeier, W. et al. | 2003
- 349
-
Immunomodulation in colorectal cancer: disappointment or promise?Pentheroudakis, G. / Pavlidis, N. et al. | 2003
- 353
-
More on the regulation of tobacco smoke: how we got here and where nextGray, N. / Kozlowski, L. T. et al. | 2003
- 358
-
Adjuvant therapy of cutaneous melanoma: the interferon debateKefford, R. F. et al. | 2003
- 367
-
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancerLicitra, L. / Locati, L. D. / Cavina, R. / Garassino, I. / Mattavelli, F. / Pizzi, N. / Quattrone, P. / Valagussa, P. / Gianni, L. / Bonadonna, G. et al. | 2003
- 373
-
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancerPivot, X. / Awada, A. / Gedouin, D. / Kerger, J. / Rolland, F. / Cupissol, D. / Caponigro, F. / Comella, G. / Lopez-Pousa, J. J. / Guardiola, E. et al. | 2003
- 378
-
Surgical adjuvant therapy of rectal carcinoma: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon-alpha2bGennatas, C. / Dardoufas, C. / Mouratidou, D. / Tsavaris, N. / Pouli, A. / Androulakis, G. / Philippakis, M. / Voros, D. / Batalis, T. / Besbeas, S. et al. | 2003
- 383
-
Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancerKim, D. Y. / Kim, J. H. / Lee, S.-H. / Kim, T. Y. / Heo, D. S. / Bang, Y.-J. / Kim, N. K. et al. | 2003
- 388
-
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic CancerStathopoulos, G. P. / Rigatos, S. K. / Dimopoulos, M. A. / Giannakakis, T. / Foutzilas, G. / Kouroussis, C. / Janninis, D. / Aravantinos, G. / Androulakis, N. / Agelaki, S. et al. | 2003
- 395
-
5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trialArkenau, H. T. / Bermann, A. / Rettig, K. / Strohmeyer, G. / Porschen, R. et al. | 2003
- 400
-
Cancer physicians' attitudes toward colorectal cancer follow-upEarle, C. C. / Grunfeld, E. / Coyle, D. / Cripps, M. C. / Stern, H. S. et al. | 2003
- 406
-
Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?Bonnefoi, H. / Diebold-Berger, S. / Therasse, P. / Hamilton, A. / van de Vijver, M. / MacGrogan, G. / Shepherd, L. / Amaral, N. / Duval, C. / Drijkoningen, R. et al. | 2003
- 414
-
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trialMustacchi, G. / Ceccherini, R. / Milani, S. / Pluchinotta, A. / De Matteis, A. / Maiorino, L. / Farris, A. / Scanni, A. / Sasso, F. et al. | 2003
- 421
-
Communication, quality of life and age: results of a 5-year prospective study in breast cancer patientsKerr, J. / Engel, J. / Schlesinger-Raab, A. / Sauer, H. / Holzel, D. et al. | 2003
- 428
-
Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancerAnelli, A. / Brentani, R. R. / Gadelha, A. P. / de Albuquerque, A. A. / Soares, F. et al. | 2003
- 433
-
A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancerParidaens, R. / Van Aelst, F. / Georgoulias, V. / Samonnig, H. / Cocquyt, V. / Zielinski, C. / Hausmaninger, H. / Willemse, P. / Boudraa, Y. / Wildiers, J. et al. | 2003
- 441
-
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupAapro, M. S. / van Wijk, F. H. / Bolis, G. / Chevallier, B. / van der Burg, M. E. L. / Poveda, A. / de Oliveira, C. F. / Tumolo, S. / di Palumbo, V. S. / Piccart, M. et al. | 2003
- 449
-
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patientsMillward, M. J. / Boyer, M. J. / Lehnert, M. / Clarke, S. / Rischin, D. / Goh, B.-C. / Wong, J. / McNeil, E. / Bishop, J. F. et al. | 2003
- 455
-
ALIMTA® (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II studySmit, E. F. / Mattson, K. / von Pawel, J. / Manegold, C. / Clarke, S. / Postmus, P. E. et al. | 2003
- 461
-
Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapyGonzalez, G. / Crombet, T. / Torres, F. / Catala, M. / Alfonso, L. / Osorio, M. / Neninger, E. / Garcia, B. / Mulet, A. / Perez, R. et al. | 2003
- 467
-
Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcomeTerol, M. J. / Tormo, M. / Martinez-Climent, J. A. / Marugan, I. / Benet, I. / Ferrandez, A. / Teruel, A. / Ferrer, R. / Garcia-Conde, J. et al. | 2003
- 475
-
CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infectionDamiani, D. / Stocchi, R. / Masolini, P. / Michelutti, A. / Geromin, A. / Sperotto, A. / Skert, C. / Michieli, M. / Baccarani, M. / Fanin, R. et al. | 2003
- 481
-
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/5-fluorouracil every 2 weeks in patients with advanced solid tumorsYchou, M. / Conroy, T. / Seitz, J. F. / Gourgou, S. / Hua, A. / Mery-Mignard, D. / Kramar, A. et al. | 2003
- 490
-
Mortality from major cancer sites in the European Union, 1955-1998Levi, F. / Lucchini, F. / Negri, E. / Boyle, P. / La Vecchia, C. et al. | 2003
- 497
-
Skin testing and hypersensitivity reactions to oxaliplatinGarufi, C. / Cristaudo, A. / Vanni, B. / Bria, E. / Aschelter, A. M. / Santucci, B. / Terzoli, E. et al. | 2003
- 499
-
Reply to Letter to the Editor on "Fertility after treatment for Hodgkin's disease", by M.K. Bohlmann, M. von Wolff & T. Strowitzki et al. (Ann Oncol 2003; 14: 499)Blumenfeld, Z. / Dann, E. J. et al. | 2003
- 499
-
Comment on the Symposium article "Fertility after treatment for Hodgkin's disease", by Z. Blumenfeld, E. Dann, I. Avivi et al. (Ann Oncol 2002; 13 Suppl 1: 138-147)Bohlmann, M. K. / von Wolff, M. / Strowitzki, T. et al. | 2003
- 500
-
Interaction between paclitaxel and warfarinThompson, M. E. / Highley, M. S. et al. | 2003
- 501
-
Severe hepatic toxicity due to thalidomide in relapsed multiple myelomaTrojan, A. / Chasse, E. / Gay, B. / Pichert, G. / Taverna, C. et al. | 2003
- 503
-
J. Lugton. Communicating with dying people and their relativesWagener, D. J. T. et al. | 2003
- 503
-
I. Higginson, A. Carr, P. Robinson (eds). Quality of LifeTamburini, M. et al. | 2003
- 505
-
Can anything be done about oral mucositis?Donnelly, J. P. / Blijlevens, N. M. A. / Verhagen, C. A. H. et al. | 2003
- 508
-
Chemoradiation therapy in locally advanced nasopharyngeal cancer: which kind of cooperation?Licitra, L. et al. | 2003
- 511
-
Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomesCella, D. / Dobrez, D. / Glaspy, J. et al. | 2003
- 520
-
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximabBoye, J. / Elter, T. / Engert, A. et al. | 2003
- 537
-
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II studyPectasides, D. / Pectasides, M. / Farmakis, D. / Bountouroglou, N. / Nikolaou, M. / Koumpou, M. / Mylonakis, N. / Kosmas, C. et al. | 2003
- 543
-
A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129Gelmon, K. A. / Vandenberg, T. A. / Panasci, L. / Norris, B. / Crump, M. / Douglas, L. / Walsh, W. / Matthews, S. J. / Seymour, L. K. et al. | 2003
- 549
-
Predictive testing for BRCA1 and 2 mutations: a male contributionDaly, P. A. / Nolan, C. / Green, A. / Ormiston, W. / Cody, N. / McDevitt, T. / O hIci, B. / Byrne, D. / McDermott, E. / Carney, D. N. et al. | 2003
- 554
-
Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow TransplantationKroger, N. / Zander, A. R. / Martinelli, G. / Ferrante, P. / Moraleda, J. M. / Da Prada, G. A. / Demirer, T. / Socie, G. / Rosti, G. et al. | 2003
- 559
-
Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled studyDazzi, C. / Cariello, A. / Giovanis, P. / Monti, M. / Vertogen, B. / Leoni, M. / Tienghi, A. / Turci, D. / Rosti, G. / Nanni, O. et al. | 2003
- 564
-
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancerOh, J. L. / Vokes, E. E. / Kies, M. S. / Mittal, B. B. / Witt, M. E. / Weichselbaum, R. R. / Haraf, D. J. et al. | 2003
- 570
-
Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I studyJames, R. D. / Botwood, N. / Vernon, C. C. / Price, P. et al. | 2003
- 574
-
Activity of raltitrexed and gemcitabine in advanced pancreatic cancerKralidis, E. / Aebi, S. / Friess, H. / Buchler, M. W. / Borner, M. M. et al. | 2003
- 580
-
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II studyAlberts, S. R. / Townley, P. M. / Goldberg, R. M. / Cha, S. S. / Sargent, D. J. / Moore, D. F. / Krook, J. E. / Pitot, H. C. / Fitch, T. R. / Wiesenfeld, M. et al. | 2003
- 586
-
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphyPanzuto, F. / Falconi, M. / Nasoni, S. / Angeletti, S. / Moretti, A. / Bezzi, M. / Gualdi, G. / Polettini, E. / Sciuto, R. / Festa, A. et al. | 2003
- 592
-
Prognostic factors for patients with advanced stage serous borderline tumours of the ovaryMorice, P. / Camatte, S. / Rey, A. / Atallah, D. / Lhomme, C. / Pautier, P. / Pomel, C. / Cote, J.-F. / Haie-Meder, C. / Duvillard, P. et al. | 2003
- 599
-
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972van den Bent, M. J. / Chinot, O. / Boogerd, W. / Marques, J. B. / Taphoorn, M. J. B. / Kros, J. M. / van der Rijt, C. C. D. / Vecht, C. J. / De Beule, N. / Baron, B. et al. | 2003
- 603
-
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naive patients with glioblastomaRaymond, E. / Fabbro, M. / Boige, V. / Rixe, O. / Frenay, M. / Vassal, G. / Faivre, S. / Sicard, E. / Germa, C. / Rodier, J. M. et al. | 2003
- 615
-
Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patientsDumontet, C. / Jaubert, J. / Sebban, C. / Bouafia, F. / Ardiet, C. / Tranchand, B. / Berger, E. / Lucas, C. / Guyotat, D. / Coiffier, B. et al. | 2003
- 623
-
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature reviewDamaj, G. / Verkarre, V. / Delmer, A. / Solal-Celigny, P. / Yakoub-Agha, I. / Cellier, C. / Maurschhauser, F. / Bouabdallah, R. / Leblond, V. / Lefrere, F. et al. | 2003
- 630
-
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursBennouna, J. / Fumoleau, P. / Armand, J.-P. / Raymond, E. / Campone, M. / Delgado, F.-M. / Puozzo, C. / Marty, M. et al. | 2003
- 638
-
Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinomaHess, V. / Verrill, M. W. / Bomphray, C. C. / Vaughan, M. M. / Allen, M. / Gore, M. E. et al. | 2003
- 643
-
Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearanceEtienne, M. C. / Leger, F. / Pivot, X. / Chatelut, E. / Bensadoun, R. J. / Guardiola, E. / Renee, N. / Magne, N. / Canal, P. / Milano, G. et al. | 2003
- 648
-
Cancer prevalence in the UK: results from the EUROPREVAL studyForman, D. / Stockton, D. / Moller, H. / Quinn, M. / Babb, P. / De Angelis, R. / Micheli, A. et al. | 2003
- 655
-
High international prognostic score predicts a worse outcome for patients with Hodgkin's disease and HIV infection: results of a prospective study with Stanford V regimenSpina, M. / Re, A. / Vaccher, E. / Gabarre, J. / Tirelli, U. et al. | 2003
- 656
-
A case study documenting the anticancer activity of ZD1839 (Iressa) in the brainVillano, J. L. / Mauer, A. M. / Vokes, E. E. et al. | 2003
- 656
-
A simple cost-effective lactate dehydrogenase level measurement can stratify patients with Ewing's tumor into low and high riskda Costa, C. M. L. / Lopes, A. / de Camargo, B. et al. | 2003
- 658
-
L-Asparaginase-associated hyperlipidemia with hyperviscosity syndrome in a patient with T-cell lymphoblastic lymphomaMeyer, B. / Hagen, W. / Scheithauer, W. / Ohler, L. / Kornek, G. V. et al. | 2003
- 659
-
Sustained partial response of an intra-abdominal desmoid tumor treated with gemcitabine, 5-fluorouracil and leucovorinWright, M. A. / Schuler, B. / Szabo, E. / Grem, J. L. et al. | 2003
- 661
-
B. Driscoll (ed). Lung Cancer. Volume II: Diagnostic and Therapeutic Methods and ReviewsHirsch, F. R. et al. | 2003
- 661
-
P.A. Pizzo, D.G. Poplack (eds). Principles and Practice of Pediatric OncologyBiondi, A. et al. | 2003
- 663
-
Anthracyclines: is more, better and/or more dangerous?Arriagada, R. / Gutierrez, J. et al. | 2003
- 667
-
The role of taxanes as a component of neoadjuvant chemotherapy for breast cancerGogas, H. / Fountzilas, G. et al. | 2003
- 675
-
Adjuvant therapy in pancreatic cancer: historical and current perspectivesNeoptolemos, J. P. / Cunningham, D. / Friess, H. / Bassi, C. / Stocken, D. D. / Tait, D. M. / Dunn, J. A. / Dervenis, C. / Lacaine, F. / Hickey, H. et al. | 2003
- 693
-
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patientsBernard-Marty, C. / Mano, M. / Paesmans, M. / Accettura, C. / Munoz-Bermeo, R. / Richard, T. / Kleiber, K. / Cardoso, F. / Lobelle, J. P. / Larsimont, D. et al. | 2003
- 699
-
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trialElomaa, I. / Joensuu, H. / Blomqvist, C. et al. | 2003
- 704
-
Prognostic value of p53 molecular status in high-risk primary breast cancerMarchetti, P. / Cannita, K. / Ricevuto, E. / De Galitiis, F. / Di Rocco, Z. C. / Tessitore, A. / Bisegna, R. / Porzio, G. / De Rubeis, G. P. / Ventura, T. et al. | 2003
- 709
-
Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI)Sekine, I. / Nishiwaki, Y. / Noda, K. / Kudoh, S. / Fukuoka, M. / Mori, K. / Negoro, S. / Yokoyama, A. / Matsui, K. / Ohsaki, Y. et al. | 2003
- 715
-
Citation indexes do not reflect methodological quality in lung cancer randomised trialsBerghmans, T. / Meert, A. P. / Mascaux, C. / Paesmans, M. / Lafitte, J. J. / Sculier, J. P. et al. | 2003
- 722
-
Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancerMauer, A. M. / Ansari, R. H. / Hoffman, P. C. / Krauss, S. A. / Taber, D. / Tembe, S. A. / Gabrys, G. T. / Cotter, T. / Schumm, L. P. / Szeto, L. et al. | 2003
- 729
-
Clinical evaluation of ricin A-chain immunotoxins in patient with Hodgkin's lymphomaSchnell, R. / Borchmann, P. / Staak, J. O. / Schindler, J. / Ghetie, V. / Vitetta, E. S. / Engert, A. et al. | 2003
- 737
-
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphomaHosing, C. / Saliba, R. M. / McLaughlin, P. / Andersson, B. / Rodriguez, M. A. / Fayad, L. / Cabanillas, F. / Champlin, R. E. / Khouri, I. F. et al. | 2003
- 745
-
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeConstans, M. / Sureda, A. / Terol, M. J. / Arranz, R. / Caballero, M. D. / Iriondo, A. / Jarque, I. / Carreras, E. / Moraleda, J. M. / Carrera, D. et al. | 2003
- 752
-
Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemiaAu, W. Y. / Lie, A. K. W. / Chim, C. S. / Liang, R. / Ma, S. K. / Chan, C. H. / Mak, Y. K. / Chen, Y. T. / So, C. C. / Yeung, Y. M. et al. | 2003
- 758
-
Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as `in vivo purge' and consolidative immunotherapy following autologous stem cell transplantationMangel, J. / Buckstein, R. / Imrie, K. / Spaner, D. / Franssen, E. / Pavlin, P. / Boudreau, A. / Pennell, N. / Combs, D. / Berinstein, N. L. et al. | 2003
- 766
-
A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weeklyStewart, D. J. / Donehower, R. C. / Eisenhauer, E. A. / Wainman, N. / Shah, A. K. / Bonfils, C. / MacLeod, A. R. / Besterman, J. M. / Reid, G. K. et al. | 2003
- 775
-
A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignanciesSchwartz, G. H. / Patnaik, A. / Hammond, L. A. / Rizzo, J. / Berg, K. / Von Hoff, D. D. / Rowinsky, E. K. et al. | 2003
- 783
-
Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumorsCastellano, D. / Hitt, R. / Ciruelos, E. / Cortes-Funes, H. / Colomer, R. et al. | 2003
- 788
-
A phase I dose-escalation study of docetaxel with granulocyte colony-stimulating factor support in patients with solid tumoursMitchell, P. L. R. / Basser, R. / Chipman, M. / Grigg, A. / Cebon, J. / Davis, I. D. / Zalcberg, J. / Ng, S. / Appia, F. / Green, M. et al. | 2003
- 795
-
Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropeniaSmith, P. F. / Birmingham, M. C. / Noskin, G. A. / Meagher, A. K. / Forrest, A. / Rayner, C. R. / Schentag, J. J. et al. | 2003
- 803
-
Breast and ovarian metastatic localization of signet-ring cell gastric carcinomaDi Cosimo, S. / Ferretti, G. / Fazio, N. / Mandala, M. / Curigliano, G. / Bosari, S. / Intra, M. / Latronico, A. / Goldhirsch, A. et al. | 2003
- 804
-
Advocating recombinant human erythropoietin as standard practice in Europe for treatment of cancer-related anaemiaCoiffier, B. et al. | 2003
- 805
-
Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117)Fiorentini, G. / Rossi, S. / Lanzanova, G. / Bernardeschi, P. / Dentico, P. / De Giorgi, U. et al. | 2003
- 805
-
Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancerAlimonti, A. / Satta, F. / Pavese, I. / Burattini, E. / Zoffoli, V. / Vecchione, A. et al. | 2003
- 806
-
Biphosphonates: new antiangiogenic molecules in cancer treatment?Vincenzi, B. / Santini, D. / Rocci, L. / Tonini, G. et al. | 2003
- 809
-
E.C. Borden (ed). Melanoma: Biologically Targeted TherapeuticsPunt, C. J. A. et al. | 2003
- 809
-
D. Schiff, P.Y. Wen (eds). Cancer Neurology in Clinical PracticeBrandes, A. A. et al. | 2003
- 810
-
D.J. Kerr, W. Bodmer, C. McArdle, M. Pignatelli (eds). Advances in Colorectal CancerZaniboni, A. et al. | 2003
- 813
-
New approaches to cancer therapyGarattini, S. et al. | 2003
- 817
-
Vaccination of patients with solid tumoursParmiani, G. / Pilla, L. / Castelli, C. / Rivoltini, L. et al. | 2003
- 825
-
Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumorsMayer, F. / Honecker, F. / Looijenga, L. H. J. / Bokemeyer, C. et al. | 2003
- 833
-
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM groupMartin, M. / Villar, A. / Sole-Calvo, A. / Gonzalez, R. / Massuti, B. / Lizon, J. / Camps, C. / Carrato, A. / Casado, A. / Candel, M. T. et al. | 2003
- 843
-
Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in ItalyRoila, F. / Ballatori, E. / Patoia, L. / Palazzo, S. / Veronesi, A. / Frassoldati, A. / Cetto, G. / Cinieri, S. / Goldhirsch, A. et al. | 2003
- 849
-
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancerXenidis, N. / Vlachonikolis, I. / Mavroudis, D. / Perraki, M. / Stathopoulou, A. / Malamos, N. / Kouroussis, C. / Kakolyris, S. / Apostolaki, S. / Vardakis, N. et al. | 2003
- 856
-
Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancerFallik, D. / Ychou, M. / Jacob, J. / Colin, P. / Seitz, J. F. / Baulieux, J. / Adenis, A. / Douillard, J. Y. / Couzigou, P. / Mahjoubi, R. et al. | 2003
- 864
-
A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignanciesYip, D. / Karapetis, C. / Strickland, A. H. / Steer, C. / Holford, C. / Knight, S. / Harper, P. et al. | 2003
- 867
-
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminomaAparicio, J. / del Muro, X. G. / Maroto, P. / Paz-Ares, L. / Alba, E. / Saenz, A. / Terrasa, J. / Barnadas, A. / Almenar, D. / Arranz, J. A. et al. | 2003
- 873
-
Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumorsMadani, A. / Kemmer, K. / Sweeney, C. / Corless, C. / Ulbright, T. / Heinrich, M. / Einhorn, L. et al. | 2003
- 881
-
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)Wunderlich, A. / Kloess, M. / Reiser, M. / Rudolph, C. / Truemper, L. / Bittner, S. / Schmalenberg, H. / Schmits, R. / Pfreundschuh, M. / Loeffler, M. et al. | 2003
- 894
-
CD117 (c-KIT) overexpression in patients with extensive-stage small-cell lung carcinomaPotti, A. / Moazzam, N. / Ramar, K. / Hanekom, D. S. / Kargas, S. / Koch, M. et al. | 2003
- 898
-
Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancersSun, W. S. / Fujimoto, J. / Tamaya, T. et al. | 2003
- 907
-
Energy, macronutrients and laryngeal cancer riskBosetti, C. / La Vecchia, C. / Talamini, R. / Negri, E. / Levi, F. / Fryzek, J. / McLaughlin, J. K. / Garavello, W. / Franceschi, S. et al. | 2003
- 913
-
Phase I and pharmacokinetic study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), using a weekly 30-minute intravenous infusion, in patients with advanced solid malignanciesBraybrooke, J. P. / Boven, E. / Bates, N. P. / Ruijter, R. / Dobbs, N. / Cheverton, P. D. / Pinedo, H. M. / Talbot, D. C. et al. | 2003
- 922
-
Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (`Iressa', ZD1839) in Japanese patients with solid malignant tumorsNakagawa, K. / Tamura, T. / Negoro, S. / Kudoh, S. / Yamamoto, N. / Takeda, K. / Swaisland, H. / Nakatani, I. / Hirose, M. et al. | 2003
- 931
-
Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumorsPunt, C. J. A. / Boni, J. / Bruntsch, U. / Peters, M. / Thielert, C. et al. | 2003
- 938
-
Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolitesFedier, A. / Schlamminger, M. / Schwarz, V. A. / Haller, U. / Howell, S. B. / Fink, D. et al. | 2003
- 946
-
Cancer prevalence in Northern Europe: the EUROPREVAL studyMoller, T. / Anderson, H. / Aareleid, T. / Hakulinen, T. / Storm, H. / Tryggvadottir, L. / Corazziari, I. / Mugno, E. et al. | 2003
- 959
-
Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimenMagagnoli, M. / Masci, G. / Carnaghi, C. / Zucali, P. A. / Castagna, L. / Morenghi, E. / Santoro, A. et al. | 2003
- 960
-
Fatal hepatic failure due to gemcitabine and vinorelbineKagohashi, K. / Funayama, Y. / Satoh, H. / Sekizawa, K. et al. | 2003
- 961
-
A case report of oxaliplatin extravasationFoo, K. F. / Michael, M. / Toner, G. / Zalcberg, J. et al. | 2003
- 962
-
Severe hemolytic anemia and skin reaction in a patient treated with imatinibDe Arriba, J.-J. / Nerin, C. / Garcia, E. / Gomez-Aldaravi, L. / Vila, B. et al. | 2003
- 962
-
Fluctuation of intratumor biological variables as a function of menstrual timing of surgery for beast cancer in premenopausal patientsCoradini, D. / Veneroni, S. / Pellizzaro, C. / Daidone, M. G. et al. | 2003
- 965
-
G.J. Schiller (ed). Chronic Leukemias and Lymphomas: Biology, Pathophysiology and Clinical ManagementSchouten, H. C. et al. | 2003
- 965
-
R. Pinkerton, T. Philip, B. Fervers (eds). Evidence-based Paediatric OncologyBiondi, A. et al. | 2003
- 966
-
J. Cassidy, D. Bisset, R.A.J. Spence (eds). Oxford Handbook of OncologyLashof, A. M. L. O. / Punt, C. J. A. et al. | 2003
- 969
-
Targeting antihormone resistance in breast cancer: a simple solutionJordan, V. C. et al. | 2003
- 971
-
Europe's eye is fixed on mighty thingsKerr, D. et al. | 2003
- 973
-
European Code Against Cancer and scientific justification: third version (2003)| 2003
- 1006
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer| 2003
- 1008
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer| 2003
- 1010
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer| 2003
- 1012
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma| 2003
- 1014
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck| 2003
- 1017
-
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancerPiccart, M. / Parker, L. M. / Pritchard, K. I. et al. | 2003
- 1026
-
Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?Graziano, F. / Cascinu, S. et al. | 2003
- 1039
-
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myelomaDimopoulos, M. A. / Pouli, A. / Zervas, K. / Grigoraki, V. / Symeonidis, A. / Repoussis, P. / Mitsouli, C. / Papanastasiou, C. / Margaritis, D. / Tokmaktsis, A. et al. | 2003
- 1045
-
Survivin and aven: two distinct antiapoptotic signals in acute leukemiasPaydas, S. / Tanriverdi, K. / Yavuz, S. / Disel, U. / Sahin, B. / Burgut, R. et al. | 2003
- 1051
-
Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activityde Graffenried, L. A. / Friedrichs, W. E. / Fulcher, L. / Fernandes, G. / Silva, J. M. / Peralba, J.-M. / Hidalgo, M. et al. | 2003
- 1057
-
Long-term medical costs of postmenopausal breast cancer therapyCocquyt, V. / Moeremans, K. / Annemans, L. / Clarys, P. / Van Belle, S. et al. | 2003
- 1064
-
Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patientsHartl, K. / Janni, W. / Kastner, R. / Sommer, H. / Strobl, B. / Rack, B. / Stauber, M. et al. | 2003
- 1072
-
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survivalMiller, K. D. / Weathers, T. / Haney, L. G. / Timmerman, R. / Dickler, M. / Shen, J. / Sledge, G. W. et al. | 2003
- 1078
-
P21^W^A^F^1, P27^K^I^P^1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimensPlisiecka-Halasa, J. / Karpinska, G. / Szymanska, T. / Ziolkowska, I. / Madry, R. / Timorek, A. / Debniak, J. / Ulanska, M. / Jedryka, M. / Chudecka-Glaz, A. et al. | 2003
- 1086
-
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patientsLorusso, D. / Ferrandina, G. / Greggi, S. / Gadducci, A. / Pignata, S. / Tateo, S. / Biamonte, R. / Manzione, L. / Di Vagno, G. / Ferrau , F. et al. | 2003
- 1094
-
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerAravantinos, G. / Bafaloukos, D. / Fountzilas, G. / Christodoulou, C. / Papadimitriou, C. / Pavlidis, N. / Kalofonos, H. P. / Gogas, H. / Kosmidis, P. / Dimopoulos, M. A. et al. | 2003
- 1100
-
A phase II study of mitomycin C, cisplatin and protracted infusional 5-fluorouracil in advanced pancreatic carcinoma: efficacy and low toxicityPetty, R. D. / Nicolson, M. C. / Skaria, S. / Sinclair, T. S. / Samuel, L. M. / Koruth, M. et al. | 2003
- 1106
-
A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancerBouzid, K. / Khalfallah, S. / Tujakowski, J. / Piko, B. / Purkalne, G. / Plate, S. / Padrik, P. / Serafy, M. / Pshevloutsky, E. M. / Boussard, B. et al. | 2003
- 1115
-
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancerKim, T. W. / Chang, H. M. / Kang, H. J. / Lee, J. R. / Ryu, M. H. / Ahn, J. H. / Kim, J. H. / Lee, J. S. / Kang, Y. K. et al. | 2003
- 1121
-
Multicenter phase II trial evaluating a three-weekly schedule of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancerAparicio, J. / Vicent, J. M. / Maestu, I. / Garcera, S. / Busquier, I. / Bosch, C. / Llorca, C. / Diaz, R. / Fernandez-Martos, C. / Galan, A. et al. | 2003
- 1126
-
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamideBacci, G. / Briccoli, A. / Rocca, M. / Ferrari, S. / Donati, D. / Longhi, A. / Bertoni, F. / Bacchini, P. / Giacomini, S. / Forni, C. et al. | 2003
- 1135
-
Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical roleCimitan, M. / Buonadonna, A. / Cannizzaro, R. / Canzonieri, V. / Borsatti, E. / Ruffo, R. / De Apollonia, L. et al. | 2003
- 1142
-
Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunctionFleming, G. F. / Schilsky, R. L. / Schumm, L. P. / Meyerson, A. / Hong, A. M. / Vogelzang, N. J. / Ratain, M. J. et al. | 2003
- 1148
-
Cancer mortality trends in the EU and acceding countries up to 2015Quinn, M. J. / d Onofrio, A. / Moller, B. / Black, R. / Martinez-Garcia, C. / Moller, H. / Rahu, M. / Robertson, C. / Schouten, L. J. / La Vecchia, C. et al. | 2003
- 1153
-
Autoantibodies in gastric MALT-type lymphomaEck, M. / Schmausser, B. / Kerkau, T. / Greiner, A. / Kraus, M. / Fischbach, W. / Muller-Hermelink, H. K. et al. | 2003
- 1154
-
Reply to Letter to the Editor "`Whose `wish bias'?", by M. Velasco-Garrido & R. Busse (Ann Oncol 2003; 14: 1154)Fossati, R. / Confalonieri, C. / Apolone, G. / Cavuto, S. / Garattini, S. et al. | 2003
- 1154
-
Whose `wish bias'?Velasco-Garrido, M. / Busse, R. et al. | 2003
- 1155
-
Early restaging positron emission tomography with ^1^8F-fluorodeoxyglucose in aggressive non-Hodgkin's lymphomas: is it too easy to be true?Balzarotti, M. / Magagnoli, M. / Santoro, A. et al. | 2003
- 1156
-
p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimensBottini, A. / Dogliotti, L. / Bersiga, A. / Brizzi, M. P. / Berruti, A. et al. | 2003
- 1157
-
P.W. Kantoff, P.R. Carroll, A.V. D'Amico (eds). Prostate Cancer: Principles and PracticeCathelineau, X. et al. | 2003
- 1159
-
Global summit on mammographic screeningBoyle, P. et al. | 2003
- 1161
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of acute myeloblastic leukaemia (AML) in adult patients| 2003
- 1163
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma| 2003
- 1165
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of osteosarcoma| 2003
- 1167
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Ewing's sarcoma of bone| 2003
- 1169
-
The Hsp90 chaperone complex as a novel target for cancer therapyGoetz, M. P. / Toft, D. O. / Ames, M. M. / Erlichman, C. et al. | 2003
- 1177
-
Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumorsRenga, M. / Pedrazzoli, P. / Siena, S. et al. | 2003
- 1185
-
Mammographic screening: evidence from randomised controlled trialsde Koning, H. J. et al. | 2003
- 1190
-
Mammographic screening: case-control studiesWalter, S. D. et al. | 2003
- 1193
-
EUSOMA review of mammography screeningHackshaw, A. et al. | 2003
- 1196
-
The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluationDuffy, S. W. / Tabar, L. / Vitak, B. / Yen, M. F. / Warwick, J. / Smith, R. A. / Chen, H. H. et al. | 2003
- 1199
-
Modelling the early detection of breast cancerLee, S. J. / Zelen, M. et al. | 2003
- 1203
-
Evaluation of The Netherlands breast cancer screening programmeVerbeek, A. L. M. / Broeders, M. J. M. et al. | 2003
- 1206
-
Evaluation of the UK breast screening programmesSasieni, P. et al. | 2003
- 1209
-
Evaluation of the organised mammographic screening programme in AustraliaGiles, G. G. / Amos, A. et al. | 2003
- 1212
-
Systemic treatments for women with breast cancer: outcome with relation to screening for the diseaseGoldhirsch, A. / Colleoni, M. / Domenighetti, G. / Gelber, R. D. et al. | 2003
- 1215
-
Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observationWaeber, M. / Castiglione-Gertsch, M. / Dietrich, D. / Thurlimann, B. / Goldhirsch, A. / Brunner, K. W. / Borner, M. M. et al. | 2003
- 1222
-
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patientsLunardi, G. / Vannozzi, M. O. / Bighin, C. / Del Mastro, L. / Stevani, I. / Schettini, G. / Venturini, M. et al. | 2003
- 1227
-
Multicenter phase II study of oral capecitabine (Xeloda®) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapyReichardt, P. / von Minckwitz, G. / Thuss-Patience, P. C. / Jonat, W. / Kolbl, H. / Janicke, F. / Kieback, D. G. / Kuhn, W. / Schindler, A. E. / Mohrmann, S. et al. | 2003
- 1234
-
Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patientsKoizumi, M. / Yoshimoto, M. / Kasumi, F. / Ogata, E. et al. | 2003
- 1241
-
Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutionsIsmail, M. S. / Wynendaele, W. / Aerts, J. L. E. / Paridaens, R. / Van Mellaert, L. / Anne, J. / Gaafar, R. / Shakankiry, N. / Khaled, H. M. / Christiaens, M. R. et al. | 2003
- 1246
-
Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclinesMartin, M. / Spielmann, M. / Namer, M. / duBois, A. / Unger, C. / Dodwell, D. / Vodvarka, P. / Lind, M. / Calvert, H. / Casado, A. et al. | 2003
- 1253
-
Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagusPolee, M. B. / Tilanus, H. W. / Eskens, F. A. L. M. / Hoekstra, R. / Van der Burg, M. E. L. / Siersema, P. D. / Stoter, G. / Van der Gaast, A. et al. | 2003
- 1258
-
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinomaCocconi, G. / Carlini, P. / Gamboni, A. / Gasperoni, S. / Rodino, C. / Zironi, S. / Bisagni, G. / Porrozzi, S. / Cognetti, F. / Di Costanzo, F. et al. | 2003
- 1264
-
A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancerMackay, H. J. / Hill, M. / Twelves, C. / Glasspool, R. / Price, T. / Campbell, S. / Massey, A. / Macham, M. A. / Uzzel, M. / Bailey, S. M. et al. | 2003
- 1270
-
Phase II study of flavopiridol in patients with advanced colorectal cancerAklilu, M. / Kindler, H. L. / Donehower, R. C. / Mani, S. / Vokes, E. E. et al. | 2003
- 1274
-
Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF~1~6~5) receptor scintigraphyLi, S. / Peck-Radosavljevic, M. / Kienast, O. / Preitfellner, J. / Hamilton, G. / Kurtaran, A. / Pirich, C. / Angelberger, P. / Dudczak, R. et al. | 2003
- 1278
-
A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiationDuenas-Gonzalez, A. / Lopez-Graniel, C. / Gonzalez-Enciso, A. / Cetina, L. / Rivera, L. / Mariscal, I. / Montalvo, G. / Gomez, E. / de la Garza, J. / Chanona, G. et al. | 2003
- 1285
-
A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinomaZarba, J. J. / Jaremtchuk, A. V. / Jazey, P. G. / Keropian, M. / Castagnino, R. / Mina, C. / Arroyo, G. et al. | 2003
- 1291
-
Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patientsDroz, J. P. / Muracciole, X. / Mottet, N. / Kaci, M. O. / Vannetzel, J. M. / Albin, N. / Culine, S. / Rodier, J.-M. / Misset, J.-L. / Mackenzie, S. et al. | 2003
- 1299
-
Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemiaDimopoulos, M. A. / Hamilos, G. / Zervas, K. / Symeonidis, A. / Kouvatseas, G. / Roussou, P. / Gika, D. / Karmiris, T. / Bourantas, K. / Zomas, A. et al. | 2003
- 1306
-
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primaryArgiris, A. / Smith, S. M. / Stenson, K. / Mittal, B. B. / Pelzer, H. J. / Kies, M. S. / Haraf, D. J. / Vokes, E. E. et al. | 2003
- 1312
-
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?Boyle, P. / d Onofrio, A. / Maisonneuve, P. / Severi, G. / Robertson, C. / Tubiana, M. / Veronesi, U. et al. | 2003
- 1327
-
A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid glandLocati, L. D. / Quattrone, P. / Bossi, P. / Marchiano, A. V. / Cantu, G. / Licitra, L. et al. | 2003
- 1328
-
Successfully treated carcinoma erysipeloides from gastric cancerIkeda, Y. / Niimi, M. / Kurihara, H. / Kodaira, S. et al. | 2003
- 1329
-
Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patientsMagne, N. / Pivot, X. / Etienne-Grimaldi, M. C. / Francois, E. / Renee, N. / Thyss, A. / Schneider, M. / Demard, F. / Milano, G. et al. | 2003
- 1330
-
Wound healing is not impaired by the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinibGovindan, R. / Behnken, D. / Read, W. / McLeod, H. et al. | 2003
- 1331
-
Radiotherapy following breast-conserving surgeryAppleton, A. L. et al. | 2003
- 1333
-
M. Page (ed). Tumor Targeting in Cancer TherapyKreitman, R. J. et al. | 2003
- 1333
-
K.N. Syrigos, K. Harrington (eds). Targeted Therapy for CancerKerr, D. J. et al. | 2003
- 1335
-
ESMO takes a stand on supportive and palliative careCherny, N. I. / Catane, R. / Kosmidis, P. et al. | 2003
- 1338
-
Anything in modulation?Gray, R. / Hills, R. / Stowe, R. et al. | 2003
- 1341
-
Hepatitis C and B-cell lymphomaTurner, N. C. / Dusheiko, G. / Jones, A. et al. | 2003
- 1346
-
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancerAtalay, G. / Cardoso, F. / Awada, A. / Piccart, M. J. et al. | 2003
- 1365
-
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)Di Costanzo, F. / Sobrero, A. / Gasperoni, S. / Dogliotti, L. / Frassineti, L. / Falcone, A. / Lionetto, R. / Bruzzi, P. / Luppi, G. / Gallo, L. et al. | 2003
- 1373
-
Postoperative chemoradiotherapy for gastric cancerPark, S. H. / Kim, D. Y. / Heo, J. S. / Lim, D. H. / Park, C. K. / Lee, K. W. / Choi, S. H. / Sohn, T. S. / Kim, S. / Noh, J. H. et al. | 2003
- 1378
-
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancerZeuli, M. / Nardoni, C. / Pino, M. S. / Gamucci, T. / Gabriele, A. / Ferraresi, V. / Giannarelli, D. / Cognetti, F. et al. | 2003
- 1383
-
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patientsBaselga, J. / Llombart-Cussac, A. / Bellet, M. / Guillem-Porta, V. / Enas, N. / Krejcy, K. / Carrasco, E. / Kayitalire, L. / Kuta, M. / Lluch, A. et al. | 2003
- 1391
-
Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancerParidaens, R. / Dirix, L. / Lohrisch, C. / Beex, L. / Nooij, M. / Cameron, D. / Biganzoli, L. / Cufer, T. / Duchateau, L. / Hamilton, A. et al. | 2003
- 1399
-
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastasesBody, J.-J. / Diel, I. J. / Lichinitser, M. R. / Kreuser, E. D. / Dornoff, W. / Gorbunova, V. A. / Budde, M. / Bergstrom, B. et al. | 2003
- 1406
-
An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancerTambaro, R. / Greggi, S. / Iaffaioli, R. V. / Rossi, A. / Pisano, C. / Manzione, L. / Ferrari, E. / Di Maio, M. / Iodice, F. / Casella, G. et al. | 2003
- 1412
-
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsyFossa, S. D. / Aass, N. / Heilo, A. / Daugaard, G. / Skakkebaek, N. / Stenwig, A. E. / Nesland, J. M. / Looijenga, L. H. J. / Oosterhuis, J. W. et al. | 2003
- 1419
-
Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumoursSantos, L. / Costa, C. / Pereira, S. / Koch, M. / Amaro, T. / Cardoso, F. / Guimaraes, T. / Bento, M. J. / Lobo, F. / Pinto, S. et al. | 2003
- 1425
-
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary siteBalana, C. / Manzano, J.-L. / Moreno, I. / Cirauqui, B. / Abad, A. / Font, A. / Mate, J.-L. / Rosell, R. et al. | 2003
- 1430
-
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactionsChanan-Khan, A. / Szebeni, J. / Savay, S. / Liebes, L. / Rafique, N. M. / Alving, C. R. / Muggia, F. M. et al. | 2003
- 1438
-
Hematologic malignancies Clinical utility of computed tomography-guided core needle biopsy in the diagnostic re-evaluation of patients with lymphoproliferative disorders and suspected disease progressionGoldschmidt, N. / Libson, E. / Bloom, A. / Amir, G. / Paltiel, O. et al. | 2003
- 1442
-
Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I studyTewes, M. / Schleucher, N. / Achterrath, W. / Wilke, H. J. / Frings, S. / Seeber, S. / Harstrick, A. / Rustum, Y. M. / Vanhoefer, U. et al. | 2003
- 1449
-
Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracyclineNakane, M. / Takahashi, S. / Sekine, I. / Fukui, I. / Koizumi, M. / Kage, K. / Ito, Y. / Aiba, K. / Horikoshi, N. / Hatake, K. et al. | 2003
- 1450
-
Laboratory variables to stratify metastatic colorectal cancer patientsWatine, J. et al. | 2003
- 1451
-
Reply to Letter to the Editor "Laboratory variables to stratify metastatic colorectal cancer patients", by J. Watine (Ann Oncol 2003; 14: 1450-1451)Kohne, C.-H. / Hecker, H. et al. | 2003
- 1453
-
P. Gresele, C.P. Page, V. Fuster, J. Vermylen (eds). Platelets in Thrombotic and Non-Thrombotic disorders: Pathophysiology, Pharmacology and TherapeuticsMannucci, P. M. et al. | 2003
- 1453
-
R.R. Barakat, M.W. Bevers, D.M. Gershenson, W.J. Hoskins (eds). Handbook of Gynecologic Oncology, 2nd editionEgli, G. et al. | 2003
- 1455
-
Continuing medical education: a must for every medical oncologistSchrijvers, D. / Vermorken, J. B. / Bokemeyer, C. / Ludwig, H. et al. | 2003
- 1460
-
Primary chemotherapy of breast cancer followed by perioperative chemotherapy: feasible, but are there clinical benefits?Joensuu, H. et al. | 2003
- 1463
-
Screening for hepatocellular carcinoma: survival benefit and cost-effectivenessYuen, M.-F. / Lai, C.-L. et al. | 2003
- 1468
-
The antineoplastic role of bisphosphonates: from basic research to clinical evidenceSantini, D. / Gentilucci, U. V. / Vincenzi, B. / Picardi, A. / Vasaturo, F. / La Cesa, A. / Onori, N. / Scarpa, S. / Tonini, G. et al. | 2003
- 1477
-
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phaseColleoni, M. / Curigliano, G. / Minchella, I. / Peruzzotti, G. / Nole, F. / Mazzarol, G. / Renne, G. / Orlando, L. / Rocca, A. / Veronesi, P. et al. | 2003
- 1484
-
Prognosis in node-negative primary breast cancer: a neural network analysis of risk profiles using routinely assessed factorsBiganzoli, E. / Boracchi, P. / Coradini, D. / Daidone, M. G. / Marubini, E. et al. | 2003
- 1494
-
Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancerKristensen, G. B. / Kildal, W. / Abeler, V. M. / Kaern, J. / Vergote, I. / Trope, C. G. / Danielsen, H. E. et al. | 2003
- 1501
-
Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancerSehouli, J. / Mustea, A. / Koensgen, D. / Chen, F. C.-K. / Lichtenegger, W. et al. | 2003
- 1505
-
Heparanase expression is an independent prognostic factor in patients with invasive cervical cancerShinyo, Y. / Kodama, J. / Hongo, A. / Yoshinouchi, M. / Hiramatsu, Y. et al. | 2003
- 1511
-
Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysisMorice, P. / Piovesan, P. / Rey, A. / Atallah, D. / Haie-Meder, C. / Pautier, P. / Sideris, L. / Pomel, C. / Duvillard, P. / Castaigne, D. et al. | 2003
- 1518
-
Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castrationSmaletz, O. / Galsky, M. / Scher, H. I. / DeLaCruz, A. / Slovin, S. F. / Morris, M. J. / Solit, D. B. / Davar, U. / Schwartz, L. / Kelly, W. K. et al. | 2003
- 1525
-
Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patientsAigner, A. / Brachmann, P. / Beyer, J. / Jager, R. / Raulais, D. / Vigny, M. / Neubauer, A. / Heidenreich, A. / Weinknecht, S. / Czubayko, F. et al. | 2003
- 1530
-
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial casesColombino, M. / Cossu, A. / Arba, A. / Manca, A. / Curci, A. / Avallone, A. / Comella, G. / Botti, G. / Scintu, F. / Amoruso, M. et al. | 2003
- 1537
-
Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial)Zelek, L. / Bugat, R. / Cherqui, D. / Ganem, G. / Valleur, P. / Guimbaud, R. / Dupuis, O. / Aziza, T. / Fagniez, P. L. / Auroux, J. et al. | 2003
- 1543
-
Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancerBajetta, E. / Celio, L. / Buzzoni, R. / Ferrari, L. / Marchiano, A. / Martinetti, A. / Longarini, R. / Becerra, C. / Ilardi, C. / John, W. et al. | 2003
- 1549
-
Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II studyFelip, E. / Rosell, R. / Domine, M. / Santome, L. / Garrido, P. / Font, A. / Carrato, A. / Terrasa, J. / Vadell, C. / Mane, J. M. et al. | 2003
- 1555
-
Limited-stage mantle-cell lymphomaLeitch, H. A. / Gascoyne, R. D. / Chhanabhai, M. / Voss, N. J. / Klasa, R. / Connors, J. M. et al. | 2003
- 1562
-
BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infectionHartmann, P. / Rehwald, U. / Salzberger, B. / Franzen, C. / Sieber, M. / Wohrmann, A. / Diehl, V. et al. | 2003
- 1570
-
Palonosetron improves prevention of chemotherapy-induced nausca and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetronGralla, R. / Lichinitser, M. / Van der Vegt, S. / Sleeboom, H. / Mezger, J. / Peschel, C. / Tonini, G. / Labianca, R. / Macciocchi, A. / Aapro, M. et al. | 2003
- 1578
-
Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patientsPivot, X. / Chamorey, E. / Guardiola, E. / Magne, N. / Thyss, A. / Otto, J. / Giroux, B. / Mouri, Z. / Schneider, M. / Milano, G. et al. | 2003
- 1587
-
Anastrozole and quinapril can be safely coadministered to elderly women with breast cancer and hypertension: a pharmacokinetic studyRepetto, L. / Vannozzi, O. / Hazini, A. / Sestini, A. / Pietropaolo, M. / Rosso, R. et al. | 2003
- 1588
-
Onycholysis secondary to multiple paclitaxel 1-hour infusions: possible role for its vehicle (Cremophor EL)De Giorgi, U. / Rosti, G. / Monti, M. / Frassineti, G. L. / Marangolo, M. et al. | 2003
- 1589
-
Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapyBerruti, A. / Saini, A. / Gorzegno, G. / Tampellini, M. / Borasio, P. / Dogliotti, L. et al. | 2003
- 1591
-
Z. Rayter, J. Mansi (eds). Medical Therapy of Breast CancerCastiglione-Gertsch, M. et al. | 2003
- 1593
-
Cancer research: joint planning for the futureNurse, P. / Pattison, J. / Radda, G. / O Toole, L. et al. | 2003
- 1595
-
Antigen- and/or immune-driven lymphoproliferative disordersAljurf, M. D. / Owaidah, T. W. / Ezzat, A. / Ibrahim, E. / Tbakhi, A. et al. | 2003
- 1607
-
Progress in the development and acquisition of anticancer agents from marine sourcesAmador, M. L. / Jimeno, J. / Paz-Ares, L. / Cortes-Funes, H. / Hidalgo, M. et al. | 2003
- 1617
-
Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patientsArriagada, R. / Le, M. G. / Guinebretiere, J.-M. / Dunant, A. / Rochard, F. / Tursz, T. et al. | 2003
- 1623
-
Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancerGanem, G. / Tubiana-Hulin, M. / Fumoleau, P. / Combe, M. / Misset, J.-L. / Vannetzel, J.-M. / Bachelot, T. / De Ybarlucea, L. R. / Lotz, V. / Bendahmane, B. et al. | 2003
- 1629
-
A trial-based cost-effectiveness analysis of letrozole followed by tamoxifen versus tamoxifen followed by letrozole for postmenopausal advanced breast cancerKarnon, J. / Johnston, S. R. D. / Jones, T. / Glendenning, A. et al. | 2003
- 1634
-
Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancerJassem, J. / Kosmidis, P. / Ramlau, R. / Zarogoulidis, K. / Novakova, L. / Breton, J. / Etienne, P.-L. / Seebacher, C. / Grivaux, M. / Ojala, A. et al. | 2003
- 1640
-
Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyEsteban, E. / de Sande, L. G. / Fernandez, Y. / Corral, N. / Fra, J. / Muniz, I. / Vieitez, J. M. / Palacio, I. / Fernandez, J. L. / Estrada, E. et al. | 2003
- 1648
-
Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective studyHuo, T.-I. / Huang, Y.-H. / Wu, J.-C. / Chiang, J.-H. / Lee, P.-C. / Chang, F.-Y. / Lee, S.-D. et al. | 2003
- 1654
-
Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997Bacci, G. / Ferrari, S. / Longhi, A. / Donati, D. / De Paolis, M. / Forni, C. / Versari, M. / Setola, E. / Briccoli, A. / Barbieri, E. et al. | 2003
- 1660
-
Paclifaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlationsStebbing, J. / Wildfire, A. / Portsmouth, S. / Powles, T. / Thirlwell, C. / Hewitt, P. / Nelson, M. / Patterson, S. / Mandalia, S. / Gotch, F. et al. | 2003
- 1667
-
Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic featuresKaufmann, H. / Ackermann, J. / Greinix, H. / Nosslinger, T. / Gisslinger, H. / Keck, A. / Ludwig, H. / Worel, N. / Kalhs, P. / Zielinski, C. et al. | 2003
- 1673
-
Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its valueAu, W. Y. / Lie, A. K. W. / Liang, R. / Kwong, Y.-L. / Yau, C.-C. / Cheung, M. M. C. / Ngan, K.-C. / Lau, W.-H. / Wong, K.-H. / Yiu, H.-Y. et al. | 2003
- 1677
-
Folate intake and risk of oral and pharyngeal cancerPelucchi, C. / Talamini, R. / Negri, E. / Levi, F. / Conti, E. / Franceschi, S. / La Vecchia, C. et al. | 2003
- 1682
-
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumorsGoel, S. / Bulgaru, A. / Hochster, H. / Wadler, S. / Zamboni, W. / Egorin, M. / Ivy, P. / Leibes, L. / Muggia, F. / Lockwood, G. et al. | 2003
- 1689
-
Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelinCarlini, P. / Di Cosimo, S. / Ferretti, G. / Papaldo, P. / Fabi, A. / Ruggeri, E. M. / Milella, M. / Cognetti, F. et al. | 2003
- 1690
-
Absence of chemotherapy-induced alopecia with paclitaxel in a case of hypothyroidism: case reportSofroniadou, S. / Kosmas, C. / Kourelis, T. / Makatsoris, T. / Koutras, A. / Onienadoum, A. / Kalofonos, H. P. et al. | 2003
- 1691
-
High incidence of severe hand-foot syndrome during capecitabine-docetaxel combination chemotherapyPark, Y. H. / Ryoo, B.-Y. / Lee, H. J. / Kim, S. A. / Chung, J.-H. et al. | 2003
- 1693
-
J.Mehta, S. Singhal (eds). MyelomaHarousseau, J. L. et al. | 2003
- 1693
-
E. Bruera, M.J. Fisch (eds). The Cambridge Handbook of Advanced Cancer CareSchrijvers, D. et al. | 2003
- i1
-
Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin's lymphoma - results from an expert meetingSneller, V. / Armitage, J. et al. | 2003
- i5
-
Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphomaZelenetz, A. D. / Hamlin, P. / Kewalramani, T. / Yahalom, J. / Nimer, S. / Moskowitz, C. H. et al. | 2003
- i11
-
Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's diseaseHertzberg, M. S. / Crombie, C. / Benson, W. / Taper, J. / Gottlieb, D. / Bradstock, K. F. et al. | 2003
- i17
-
Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphomaVose, J. / Sneller, V. et al. | 2003
- i21
-
A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT)Joyce, R. M. / Regan, M. / Ottaway, J. / Umiel, T. / Tetreault, J.-C. / Levine, J. / McDermott, D. / Hurley, D. / Giallombardo, N. / Smith, T. et al. | 2003
- i29
-
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patientsNowrousian, M. R. / Waschke, S. / Bojko, P. / Welt, A. / Schuett, P. / Ebeling, P. / Flasshove, M. / Moritz, T. / Schuette, J. / Seeber, S. et al. | 2003
- i37
-
Hodgkin's lymphoma: what is next in salvage treatment?Gisselbrecht, C. et al. | 2003
- i39
-
Ifosfamide salvage treatment before autologous stem cell transplantation in patients with refractory and relapsed Hodgkin's lymphoma: a GELA experienceGisselbrecht, C. / Mounier, N. / Ferme, C. / Brice, P. et al. | 2003
- i43
-
Ifosfamide, epirubicin and etoposide (IEV) in non-Hodgkin's lymphoma and Hodgkin's disease: the Italian experienceZinzani, P. L. et al. | 2003
- i47
-
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)Proctor, S. J. / Jackson, G. H. / Lennard, A. / Angus, B. / Wood, K. / Lucraft, H. L. / White, J. / Windebank, K. / Taylor, P. R. A. et al. | 2003
- ii1
-
Progress in the treatment of gastrointestinal cancerMassidda, B. / Rougier, P. et al. | 2003
- ii3
-
Epidemiology, treatment and chemoprevention in colorectal cancerRougier, P. / Mitry, E. et al. | 2003
- ii7
-
Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapyDouillard, J.-Y. / Sobrero, A. / Carnaghi, C. / Comella, P. / Diaz-Rubio, E. / Santoro, A. / Van Cutsem, E. et al. | 2003
- ii13
-
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastasesAdam, R. et al. | 2003
- ii17
-
Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiersDucreux, M. / Kohne, C.-H. / Schwartz, G. K. / Vanhoefer, U. et al. | 2003
- ii25
-
Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factorsCascinu, S. / Georgoulias, V. / Kerr, D. / Maughan, T. / Labianca, R. / Ychou, M. et al. | 2003
- ii31
-
Gastric cancer: epidemiology, pathology and treatmentAlberts, S. R. / Cervantes, A. / van de Velde, C. J. H. et al. | 2003
- ii37
-
Irinotecan in the treatment of gastric cancerBugat, R. et al. | 2003
- ii41
-
Docetaxel-based chemotherapy in the treatment of gastric cancerRoth, A. D. / Ajani, J. et al. | 2003
- ii45
-
Future strategies and adjuvant treatment of gastric cancerFalcone, A. et al. | 2003
- ii49
-
Current treatments and future perspectives in colorectal and gastric cancerWilke, H.-J. / Van Cutsem, E. et al. | 2003
-
5th National Congress of Medical Oncology 21-24 October, 2003: Rome, ItalyCognetti, F. / Di Costanzo, F. et al. | 2003
-
Educational and Abstract Book of the ESMO Summer Educational Conference 19-22 June, 2003: Edinburgh, Scotland, UKESEC Working Party et al. | 2003